The Promise and Therapeutic Potential of Human ES and iPS Cells

The Promise and Therapeutic Potential of Human ES and iPS Cells

Saved in:

Bibliographic Details
Main Authors:	Shi-Jiang Lu, Randall J. Lee, Claudio Napoli, Steve Oh, Erin A. Kimbrel, Qiang Feng
Format:	Article
Language:	English
Published:	Wiley 2011-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.4061/2011/959275
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Potential of iPS Cells in Synucleinopathy Research
by: Leonhard Linta, et al.
Published: (2012-01-01)

An ES-like pluripotent state in FGF-dependent murine iPS cells.
by: Bruno Di Stefano, et al.
Published: (2010-12-01)

Physiological characterisation of human iPS-derived dopaminergic neurons.
by: Elizabeth M Hartfield, et al.
Published: (2014-01-01)

Mechanosensitive Differentiation of Human iPS Cell-Derived Podocytes
by: Yize Zhang, et al.
Published: (2024-10-01)

Effect of iPS cell culture medium on the differentiation potential of induced cardiac tissues
by: Yoshiki Nakashima, et al.
Published: (2025-08-01)

Potential Clinical Applications for Human Pluripotent Stem Cell-Derived Blood Components
by: Erin A. Kimbrel, et al.
Published: (2011-01-01)

Researcb on Private IP Address Mutiplexing in Mobile PS Domain
by: Hui Xiao, et al.
Published: (2014-07-01)

Myogenic Differentiation from MYOGENIN-Mutated Human iPS Cells by CRISPR/Cas9
by: Koki Higashioka, et al.
Published: (2017-01-01)

Distinct iPS Cells Show Different Cardiac Differentiation Efficiency
by: Yohei Ohno, et al.
Published: (2013-01-01)

Retention of locally injected human iPS cell-derived cardiomyocytes into the myocardium using hydrolyzed gelatin
by: Jun Iida, et al.
Published: (2025-02-01)

Development of allogeneic iPS cell‐based therapy: from bench to bedside
by: David H McKenna, et al.
Published: (2022-12-01)

Effect of mechanical stretching stimulation on maturation of human iPS cell-derived cardiomyocytes co-cultured with human gingival fibroblasts
by: Mengxue Wang, et al.
Published: (2025-08-01)

Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling
by: SungWoo Choi, et al.
Published: (2022-09-01)

Regulation of Induced Pluripotent Stem Cells(iPS) Differentiation and Disease Model Establishment
by: Qi Xinyue
Published: (2025-01-01)

A novel machine learning based approach for iPS progenitor cell identification.
by: Haishan Zhang, et al.
Published: (2019-12-01)

Generation of hypoimmunogenic universal iPS cells through HLA-type gene knockout
by: Juryun Kim, et al.
Published: (2025-03-01)

Time-efficient strategies in human iPS cell-derived pancreatic progenitor differentiation and cryopreservation: advancing towards practical applications
by: Elena Genova, et al.
Published: (2024-12-01)

Proteomic Approach Using DIA-MS Identifies Morphogenesis-Associated Proteins during Cardiac Differentiation of Human iPS Cells
by: Takaya Urasawa, et al.
Published: (2024-12-01)

Suv4-20h abrogation enhances telomere elongation during reprogramming and confers a higher tumorigenic potential to iPS cells.
by: Rosa M Marión, et al.
Published: (2011-01-01)

Simultaneous optical recording of action potentials and calcium transients in cardiac single cells differentiated from type 1 CPVT-iPS cells
by: Tadashi Takaki, et al.
Published: (2025-06-01)

Correction: Efficient Generation of Fully Reprogrammed Human iPS Cells via Polycistronic Retroviral Vector and a New Cocktail of Chemical Compounds
Published: (2012-01-01)

Cardiotoxicity Assessment of EGFR Tyrosine Kinase Inhibitors Using Human iPS Cell‐Derived Cardiomyocytes and FDA Adverse Events Reporting System
by: Shota Yanagida, et al.
Published: (2025-08-01)

Allogenic mitochondria transfer improves cardiac function in iPS-cell-differentiated cardiomyocytes of a patient with Barth syndrome
by: Ye Seul Kim, et al.
Published: (2025-06-01)

Extracellular Matrix-Dependent Generation of Integration- and Xeno-Free iPS Cells Using a Modified mRNA Transfection Method
by: Kang-In Lee, et al.
Published: (2016-01-01)

High-throughput robotic isolation of human iPS cell clones reveals frequent homozygous induction of identical genetic manipulations by CRISPR-Cas9
by: Gou Takahashi, et al.
Published: (2025-06-01)

Air-liquid interface culture alters the characteristics and functions of monolayers generated from human iPS cell‑derived enterocyte‑like cell organoids
by: Tatsuya Inui, et al.
Published: (2025-06-01)

Concise Review: Are Stimulated Somatic Cells Truly Reprogrammed into an ES/iPS-Like Pluripotent State? Better Understanding by Ischemia-Induced Multipotent Stem Cells in a Mouse Model of Cerebral Infarction
by: Takayuki Nakagomi, et al.
Published: (2015-01-01)

Transcriptomic Profiling of iPS Cell-Derived Hepatocyte-like Cells Reveals Their Close Similarity to Primary Liver Hepatocytes
by: Saqlain Suleman, et al.
Published: (2025-06-01)

Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue.
by: Megu Yamaguchi Baden, et al.
Published: (2015-01-01)

Correction: High-throughput robotic isolation of human iPS cell clones reveals frequent homozygous induction of identical genetic manipulations by CRISPR-Cas9
by: Gou Takahashi, et al.
Published: (2025-08-01)

TMEM182 inhibits myocardial differentiation of human iPS cells by maintaining the activated state of Wnt/β‐catenin signaling through an increase in ILK expression
by: Hirofumi Morihara, et al.
Published: (2024-11-01)

VEGF Contributes to Mesenchymal Stem Cell-Mediated Reversion of Nor1-Dependent Hypertrophy in iPS Cell-Derived Cardiomyocytes
by: Denise Philipp, et al.
Published: (2021-01-01)

PS
by: David Groves
Published: (2025-01-01)

PS
by: David Groves
Published: (2024-01-01)

PS
by: Lucy Long
Published: (2022-03-01)

PS
Published: (2021-03-01)

PS
by: David Groves
Published: (2021-11-01)

PS
by: David Groves
Published: (2022-11-01)

Establishment of iPS cell line (SDQLCHi080-A) from a patient with GM1 gangliosidosis due to GLB1 mutation
by: Jingyun Guan, et al.
Published: (2024-12-01)

Generation of a gene-corrected isogenic human iPS cell line (CSUASOi006-A-2) from a retinitis pigmentosa patient using CRISPR/Cas9 technology
by: Hang Chen, et al.
Published: (2025-08-01)